Atrial fibrillation (AF) underlies almost one third of all ischaemic strokes, with the left atrial
appendage (LAA) identified as the primary thromboembolic source. Current stroke risk …

Despite the unprecedented advances in the left atrial appendage occlusion field, device-
related thrombus (DRT) remains an unresolved issue with the therapy. This paper aims to …

Background. Atrial fibrillation (AF) is considered the most common human arrhythmia. In
nonvalvular AF, around 99% of thrombi are formed in the left atrial appendage (LAA) …

Thrombus formation on intracardiac devices remains a subject of importance, with rates in
the 2-5% range. Device-related thrombus (DRT) following left atrial appendage occlusion is …

Left atrial appendage occlusion devices (LAAO) are a feasible alternative for non-valvular
atrial fibrillation (AF) patients at high risk of thromboembolic stroke and contraindication to …

Stroke, a major global health concern often rooted in cardiac dynamics, demands precise
risk evaluation for targeted intervention. Current risk models, like the CHA 2 DS 2-VASc …

Background Atrial fibrillation (AF) patients are at high risk of stroke with∼ 90% clots
originating from the left atrial appendage (LAA). Clinical understanding of blood-flow based …

Background Device-related thrombus (DRT) after left atrial appendage occlusion (LAAO) is
potentially linked to adverse events. Although clinical reports suggest an effect of the device …

Atrial fibrillation (AF) is one of the most investigated arrhythmias since it is associated with a
five-fold increase in the risk of strokes. Left atrium dilation and unbalanced and irregular …

Atrial fibrillation (AF) is associated with a fivefold increased risk of cerebrovascular events,
contributing to 15–18% of all strokes. Stroke prevention in clinical practice is typically guided …